JP2024544586A5 - - Google Patents

Info

Publication number
JP2024544586A5
JP2024544586A5 JP2024529704A JP2024529704A JP2024544586A5 JP 2024544586 A5 JP2024544586 A5 JP 2024544586A5 JP 2024529704 A JP2024529704 A JP 2024529704A JP 2024529704 A JP2024529704 A JP 2024529704A JP 2024544586 A5 JP2024544586 A5 JP 2024544586A5
Authority
JP
Japan
Prior art keywords
disorder
alkenyl
haloalkenyl
haloalkyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529704A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2022/051422 external-priority patent/WO2023092195A1/en
Publication of JP2024544586A publication Critical patent/JP2024544586A/ja
Publication of JP2024544586A5 publication Critical patent/JP2024544586A5/ja
Pending legal-status Critical Current

Links

JP2024529704A 2021-11-26 2022-11-28 Sert、dat、および/またはnet活性を調節するためのmdmaの類縁体 Pending JP2024544586A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2021903836 2021-11-26
AU2021903836A AU2021903836A0 (en) 2021-11-26 Analogues
AU2022901261 2022-05-12
AU2022901261A AU2022901261A0 (en) 2022-05-12 Analogues
PCT/AU2022/051422 WO2023092195A1 (en) 2021-11-26 2022-11-28 Analogues of mdma for modulating sert, dat, and / or net activity

Publications (2)

Publication Number Publication Date
JP2024544586A JP2024544586A (ja) 2024-12-03
JP2024544586A5 true JP2024544586A5 (cg-RX-API-DMAC7.html) 2025-12-03

Family

ID=86538463

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529704A Pending JP2024544586A (ja) 2021-11-26 2022-11-28 Sert、dat、および/またはnet活性を調節するためのmdmaの類縁体

Country Status (5)

Country Link
EP (1) EP4436964A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024544586A (cg-RX-API-DMAC7.html)
AU (1) AU2022399234A1 (cg-RX-API-DMAC7.html)
CA (1) CA3239040A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023092195A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3519816A4 (en) 2016-09-29 2020-05-06 The Regents of the University of California CONNECTIONS FOR INCREASING NEURONAL PLASTICITY
KR102946120B1 (ko) 2019-02-27 2026-03-30 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
WO2022221415A2 (en) 2021-04-13 2022-10-20 The Regents Of The University Of California Tetracyclic compounds for treating brain disorders
JP2025502615A (ja) 2021-12-15 2025-01-28 デリックス セラピューティクス,インク. フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005154350A (ja) * 2003-11-26 2005-06-16 Japan Science & Technology Agency 不斉アリルアミンの合成方法
AU2004309067B2 (en) * 2003-12-23 2009-12-17 Basf Aktiengesellschaft 1-(azolin-2-yl) amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes

Similar Documents

Publication Publication Date Title
Forrer et al. Experimental physiological studies with lysergic acid diethylamide (LSD-25)
CN1206996C (zh) 用于治疗或预防睡眠障碍的药物组合物
CN105143190A (zh) 作为mao抑制剂的被取代的萘啶和喹啉化合物
JP2002535408A5 (cg-RX-API-DMAC7.html)
JP2024521747A5 (cg-RX-API-DMAC7.html)
JP2004534065A (ja) 疾患治療用のキヌクリジン置換二環系へテロ芳香族化合物
WO2022261263A1 (en) Methods of treating neuropsychiatric disorders
CN1160360C (zh) 用于增强突触应答的氧氮杂萘化合物
US7566725B2 (en) Imidazo[1,2-A] pyridine anxiolytics
JP2019511548A5 (cg-RX-API-DMAC7.html)
EP4436964A1 (en) Analogues of mdma for modulating sert, dat, and / or net activity
WO2017007755A1 (en) Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
WO2025010308A2 (en) Mdma enantiomer compositions and methods for modulating aggression response
JP2025530256A (ja) ストレス関連障害の治療のためのmdmaの使用
WO2019220138A1 (en) Ketamine derivatives to treat neurological or psychological diseases
CN1186020C (zh) 用于提高突触应答的酰基苯并噁嗪
Sandyk A drug naive parkinsonian patient successfully treated with weak electromagnetic fields
US20250333371A1 (en) Compounds
AU2003302911A1 (en) Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compostions and preparations thereof
WO2022217247A1 (en) Isochroman derivatives and compositions and uses thereof
JP2015524456A (ja) ピペラジノ[1,2−a]インドール−1−オン類及び[1,4]ジアゼピノ[1,2−a]インドール−1−オン
TWI404542B (zh) 用於治療抽動症及具有感覺運動門控不良之精神疾病的海州常山屬組合物
CN1306532A (zh) 新的吡咯并(3,4-b)喹啉衍生物,其制备方法及其作为药物的用途
JP2008524236A5 (cg-RX-API-DMAC7.html)
WO2004099202A1 (en) Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases